BioCentury
ARTICLE | Finance

Chipscreen sets high standard in Shanghai debut

Chipscreen’s robust debut could entice companies to choose a Shanghai listing over one in Hong Kong

August 12, 2019 12:40 PM UTC

Chipscreen became the first biopharma to begin trading on Shanghai’s STAR market this week, and the strength of its debut could entice companies sitting on the sidelines to choose a mainland listing over one in Hong Kong.

Shares of Shenzhen Chipscreen Biosciences Ltd. (Shanghai:688321) rocketed through their first day of trading Monday to add about RMB37.4 billion ($4.2 billion) to the company’s market cap. ...